Covers
Nature Immunology 25
Nature Immunology 23
Cell 166
Science Trans Med 13
Cell Chemical Biology 30
Cell 166
Nature 454
IAVI Report 22
Immunity 43
Cell Host Microbe 23
Immunity 54
Science 340
Immunity 49
Cell Reports 30
Cell Metabolism 36
Trends Microbiology 24
Immunity 10
Immunity 44
Immunity 49
Cell Reports 35
ACS Chemical Biology 16
2D & 3D Illustrations
Mirror
mRNA-LNP
Fab
Immunity 30
SARS-CoV-2
Crown & Scepter
Antibody Anchor
Trimer Light Bulb
Spring Time
Covid Virions Contained
HCV Tangle
Antibody Racetrack
Hammer & Chisel Antibody
Germinal Center Ice
Antibody Foosball
Ebola Fields
Antibody Ships
Antibodies & HIV Trimer
Cell Dance
Zika Capsids & Antbodies
Lassa Blueprint
Clarthins Fields
Graphical Abstracts & Figures
HIV Replication Cycle
Diverse Array of Disease-Causing Agents
A diverse array of disease-causing agents and glycan antigens are targeted by existing and developmental carbohydrate vaccines Bacteria: capsular polysaccharide repeats associated with particular species (and serotypes). Fungi: β-glucan (Candida, Cryptococcus and Aspergillus), β-mannan (Candida), common GXM motifs for serotypes A-D (Cryptococcus). Parasites: synthetic GPI motif (Plasmodium falciparum), common tyvelose-containing Ag (Trichinella), LDN(F) (Schistosoma), common LPG (Leishmania). Viruses: high mannose, GlcNAc2Man9 (HIV). Tumours: common glycan antigens associated with glycolipids (Globo H, Fucosyl GM1, LeY) and glycoproteins (TF, LeY, Tn, sTn and PSA) found on various malignant tissues.
Rift Valley Fever Virus
Relationships of Tfh Cells to Diseases
Immunodominance in Protective B cell Responses
Targets of T Cell Responses to SARS-CoV-2…
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Elicitation of Highly Protective Anti-Malarial Antibodies in a Humanized Mouse Model
Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses
COVID Natural, Vaccine & Hybrid Immunity to SARS-CoV-2 variants
Humoral and cellular immune memory to four COVID-19 vaccines
Clients
